pillbase.ru

Dalbavancin

Active substance: dalbavancin

INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · DALBAVANCIN HYDROCHLORIDE 500 mg/25mL

United StatesActive

Marketing holder: Somerset Therapeutics, LLC

Verified 2026-10-09 · openFDA NDC

Analogues in other countries
Composition
Analogues by country

Products with the same active substance registered in other countries.

CountryProducts
RU 1
  • Ксидалба
    лиофилизат для приготовления концентрата для приготовления раствора для инфузий, 500 мг, (original in Russian, GRLS)
    ЛП-004255
    Азиенде Кимике Риуните Анжелини Франческо А.К.Р.А.Ф. С.п.А.
EU 1
  • Xydalba
    dalbavancin hydrochloride
    EMEA/H/C/002840
    AbbVie Deutschland GmbH & Co. KG
Import and control

Control by country

  • Russiaprescription only

    Source: GRLS (Russian state register) · record 01a120c4-b959-799d-bd9e-21ab5521256b;count=1 · valid from 2026-10-09 · verified 2026-10-09

  • United Statesprescription only

    Source: openFDA NDC · record 01a12091-ed18-727b-963e-01d8cab8e9f7,01a12092-8e6b-73ae-a4e9-563caa88f6cb,01a12092-9c23-7680-a864-33866e296665,01a12094-b5a7-7a6e-9ca7-564ca7bd0e4c,01a1209a-1fe9-7157-aa4a-66a74239bd32;count=7 · valid from 2026-10-09 · verified 2026-10-09

More on control status
Registration
Registration number
70069-830
Registration status
Active
Dispensing
Prescription only
Route
INTRAVENOUS
Sources
  • product · openFDA NDC · 70069-830 · Verified 2026-10-09 · open in source
  • registration_status · openFDA NDC · 70069-830 · Verified 2026-10-09 · open in source
  • ingredients.0 · openFDA NDC · 70069-830 · Verified 2026-10-09 · open in source